OKAYAMA Naoko 岡山直子

Researcher Number	40420541
Affiliation (based on the past Project Information) *help	2016: 山口大学, 医学部附属病院, 副臨床衛生検査技師長 2014 – 2015: 山口大学, 医学部附属病院, 副臨床・衛生検査技師長 2014 – 2015: 山口大学, 医学部附属病院・副臨床, 衛生検査技師長 2013: 山口大学, 医学部附属病院, 副臨床検査技師長 2008 – 2011: 山口大学, 医学部附属病院, 副臨床・衛生検査技師長 2007 – 2008: 山口大学, 医学部附属病院, 副臨床検査技師長
Review Section/Research Field	Except Principal Investigator Digestive surgery / General surgery / Laboratory medicine / Hygiene
Keywords	Except Principal Investigator 遺伝子多型 / 化学療法 / 大腸癌 / UGT1A1 / イリノテカン / 副作用予測 / 抗癌剤 / 副作用 / サイトカイン / メチル化 … More / 便DNA検査 / 食習慣 / 小児 / 糖代謝 / EGFR / P13K / cetuximab / Cetuximab / UGT1As / Irinotecan / PI3K / BRAF / KRAS / セツキシマブ / ^6 / ^28 / 6 / 28 / UGT1Ai / 毒性 Less

Development of prediction system for chemotherapy-induced side effects based on cytokine gene polymorphism
- Principal Investigator
  
  SAKAMOTO Kazuhiko
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Yamaguchi University
Stool DNA testing for detection of colorectal tumors
- Principal Investigator
  
  SUEHIRO Yutaka
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Laboratory medicine
- Research Institution
  Yamaguchi University
glucose metabolism
- Principal Investigator
  
  OKUDA Masayuki
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hygiene
- Research Institution
  Yamaguchi University
Novel strategy for prediction of toxicity and efficacy of chemotherapy for patients with metastatic colorectal cancer.
- Principal Investigator
  
  HAZAMA Shoichi
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Yamaguchi University
The polymorphisms can predict the adverse effects of chemotherapy in patients with colorectal cancer
- Principal Investigator
  
  HAZAMA Shoichi
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Yamaguchi University

All 2013 2011 2010 2009 2008 2007

All Journal Article Presentation

[Journal Article] Fat-mass and obesity-associated gene variant and changes of body mass index from ages 3 to 13 years.2013
- Author(s)
  Shinozaki K, Okuda M, Hinoda Y, Okayama N, Fukuda T, Kunitsugu I.
- Journal Title
  
  Obesity Reseach and Clinical Practice
  
  Volume: online Issue: 4 Pages: e382-e387
- DOI
  10.1016/j.orcp.2013.07.005
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24500832, KAKENHI-PROJECT-24590748
[Journal Article] The Importance of Evaluation of DNA Amplificability in KRAS Mutation Testing with Dideoxy Sequencing using Formalin-fixed and Paraffin-embedded Colorectal Cancer Tissues2011
- Author(s)
  Naoko Okayama, et al.
- Journal Title
  
  Jaapnese Journal of Clinical Oncology
  
  Volume: 41 Pages: 165-171
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591725
[Journal Article] The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues2010
- Author(s)
  Okayama N, Nishioka M, Hazama S, Sakai K, Suehiro Y, Maekawa M, Sakamoto J, Iwamoto S, Kato T, Mishima H, Oka M, Hinoda Y
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 41(2): 165-71
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591725
[Journal Article] Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1^* 28 polymorphism2009
- Author(s)
  Hazama S, Nagashima A, Kondo H, Yoshida S, Shimizu R, Araki A, Yoshino S, Okayama N, Hinoda Y, Oka M
- Journal Title
  
  Cancer Sci
  
  Volume: 101(3): 722-7
- NAID
  10026589707
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591725
[Journal Article] UGT1A1 *6 is a predictive marker of severe neutropenia for metastatic CRC patients received FOLFIRI in JAPAN2008
- Author(s)
  S. Hazama, Y. Okuyama, T. Kato, K. Takahashi, H. Nozawa, N. Okayama, Y. Hinoda, M. Oka, J. Sakamoto, H. Mishima
- Journal Title
  
  Annals of Oncology 19
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591545
[Journal Article] UGT1As polymorphisms predict toxicity in colorectal cancer patients treated with different recommended doses of irinotecan oriented by UGT1A1*28 polymorphism based on previous phase I study2007
- Author(s)
  S. Hazama, H. Kondo, S. Yoshida, R. Shimizu, H. Ozasa, T. Yamamoto, A. Araki, S. Yoshino, N. Okayama, Y. Hinoda, M. Oka
- Journal Title
  
  Journal of Clinical Oncology 25
  
  Pages: 14511-14511
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591545
[Presentation] UGTIA多型の遺伝子型サブセット選択はFOLFIRI投与mCRC患者の毒性及び腫瘍反応性を予測する(Genotype subset selection of UGTIAs polymorphisms can predict toxicity and tumor response of mCRC pts received FOLFIRI)(英語)2009
- Author(s)
  硲彰一, 日野田裕治, 岡山直子, 浜本義彦, 藤田悠介, 三嶋秀行, 坂本純一, 岡正朗
- Organizer
  日本癌学会
- Place of Presentation
  横浜パシフィコ横浜
- Year and Date
  2009-10-03
- Data Source
  KAKENHI-PROJECT-21591725
[Presentation] UGT1A1 *6 is a predictive marker of severe neutropenia for metastatic CRC patients received FOLFIRI in JAPAN2008
- Author(s)
  S. Hazama, Y. Okuyama, T. Kato, K. Takahashi, H. Nozawa, N. Okayama, Y. Hinoda, M. Oka, J. Sakamoto, H. Mishima
- Organizer
  The 33rd ESMO (European society of medical oncology) Congress
- Place of Presentation
  Stockholm, Sweden
- Data Source
  KAKENHI-PROJECT-19591545
[Presentation] UGT1As polymorphisms predict toxicity in colorectal cancer patients treated with different recommended doses of irinotecan oriented by UGT1A1*28 polymorphism based on previous phase I study2007
- Author(s)
  S. Hazama, H. Kondo, S. Yoshida, R. Shimizu, H. Ozasa, T. Yamamoto, A. Araki, S. Yoshino, N. Okayama, Y. Hinoda, M. Oka
- Organizer
  2007 ASCO Annual Meeting
- Place of Presentation
  Chicago/IL/USA
- Data Source
  KAKENHI-PROJECT-19591545

1. SAKAMOTO Kazuhiko (50420526)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
2. HAZAMA Shoichi (50253159)

# of Collaborated Projects: 2 results

# of Collaborated Products: 7 results
3. OKUDA Masayuki (50274171)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. SUEHIRO Yutaka (40290978)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. FUJITA Yusuke (40509527)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

OKAYAMA Naoko 岡山 直子

Research Projects

Research Products

Co-Researchers

Development of prediction system for chemotherapy-induced side effects based on cytokine gene polymorphism

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Stool DNA testing for detection of colorectal tumors

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

glucose metabolism

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Novel strategy for prediction of toxicity and efficacy of chemotherapy for patients with metastatic colorectal cancer.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The polymorphisms can predict the adverse effects of chemotherapy in patients with colorectal cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Fat-mass and obesity-associated gene variant and changes of body mass index from ages 3 to 13 years.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Importance of Evaluation of DNA Amplificability in KRAS Mutation Testing with Dideoxy Sequencing using Formalin-fixed and Paraffin-embedded Colorectal Cancer Tissues2011

Author(s)

Journal Title

Data Source

[Journal Article] The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues2010

Author(s)

Journal Title

Data Source

[Journal Article] Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1^* 28 polymorphism2009

Author(s)

Journal Title

NAID

Data Source

[Journal Article] UGT1A1 *6 is a predictive marker of severe neutropenia for metastatic CRC patients received FOLFIRI in JAPAN2008

Author(s)

Journal Title

Data Source

[Journal Article] UGT1As polymorphisms predict toxicity in colorectal cancer patients treated with different recommended doses of irinotecan oriented by UGT1A1*28 polymorphism based on previous phase I study2007

Author(s)

Journal Title

Data Source

[Presentation] UGTIA多型の遺伝子型サブセット選択はFOLFIRI投与mCRC患者の毒性及び腫瘍反応性を予測する(Genotype subset selection of UGTIAs polymorphisms can predict toxicity and tumor response of mCRC pts received FOLFIRI)(英語)2009

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] UGT1A1 *6 is a predictive marker of severe neutropenia for metastatic CRC patients received FOLFIRI in JAPAN2008

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] UGT1As polymorphisms predict toxicity in colorectal cancer patients treated with different recommended doses of irinotecan oriented by UGT1A1*28 polymorphism based on previous phase I study2007

Author(s)

Organizer

Place of Presentation

Data Source

OKAYAMA Naoko 岡山直子